Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.20
-0.03 (-0.57%)
Nov 21, 2024, 4:00 PM EST - Market closed
Journey Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Journey Medical stock have an average target of 9.50, with a low estimate of 8.50 and a high estimate of 11. The average target predicts an increase of 82.69% from the current stock price of 5.20.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 6, 2024.
Analyst Ratings
The average analyst rating for DERM stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +73.08% | Sep 6, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +111.54% | Jun 28, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +63.46% | Feb 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +15.38% | Sep 7, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +15.38% | Jul 12, 2023 |
Financial Forecast
Revenue This Year
58.27M
from 79.18M
Decreased by -26.41%
Revenue Next Year
80.05M
from 58.27M
Increased by 37.38%
EPS This Year
-1.19
from -0.21
EPS Next Year
-0.07
from -1.19
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 60.4M | 91.7M | 83.6M |
| Avg | 58.3M | 80.0M | 81.2M |
| Low | 55.6M | 62.6M | 78.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -23.7% | 57.4% | 4.4% |
| Avg | -26.4% | 37.4% | 1.4% |
| Low | -29.8% | 7.5% | -2.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.98 | 0.45 | -0.44 |
| Avg | -1.19 | -0.07 | -0.43 |
| Low | -1.54 | -0.77 | -0.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.